RAPT Therapeutics Announces Late-Breaking Oral Presentation of Positive Results from Phase 1B Trial of RPT193 at the 30th European Academy of Dermatology and Venereology Congress
September 30, 2021
September 2021
Ribon Therapeutics Named a “Fierce 15” Biotech Company by Fierce Biotech
September 27, 2021
Dr. Sarah Gillmor Hymowitz joins The Column Group as Venture Partner
The Column Group announces the hiring of Dr. Sarah Gillmor Hymowitz. Previously, Dr. Hymowitz spent 22 years at Genentech rising to Vice President of Protein Sciences. In this role, she oversaw the large molecule drug discovery portfolio and mentored project teams on the identification and optimization of more than 35 clinical candidates.
TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow
Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s new fellowship program pays homage to Robert Swanson’s legacy, empowering the next generation of young visionaries on their quest to better the world through science and medicine. The Column Group …
TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow Read More »
Ribon Therapeutics Announces Key Management Promotions
September 1, 2021
